RCMI Coordinating Center (RCMI CC) Header Logo

Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18?kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition.

Agusti A, Dziedzic JL, Hernandez-Rabaza V, Guilarte TR, Felipo V. Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18?kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition. Metab Brain Dis. 2014 Dec; 29(4):955-63.

View in: PubMed

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support